1.
Arch Cardiovasc Dis
; 117(4): 297-300, 2024 Apr.
Article
in English
| MEDLINE
| ID: mdl-38494401
2.
Bull Cancer
; 110(10): 986-988, 2023 10.
Article
in French
| MEDLINE
| ID: mdl-37661551
3.
4.
Platelets
; 33(4): 652-653, 2022 May 19.
Article
in English
| MEDLINE
| ID: mdl-35225144
ABSTRACT
In 2021, the world experienced the most extensive vaccination campaign to defeat COVID-19. Many cases of idiopathic thrombocytopenia have been reported following injections of SARS-Cov-2 mRNA vaccine. We present the case of a 73-year-old woman with de novo ITP after a first injection of SARS-Cov-2 mRNA vaccine (Moderna vaccine) who experienced a successful rechallenge of SARS-Cov-2 mRNA vaccine (Pfizer vaccine) a few months later.
Subject(s)
COVID-19 , Purpura, Thrombocytopenic, Idiopathic , Vaccines , Aged , COVID-19 Vaccines/adverse effects , Female , Humans , Purpura, Thrombocytopenic, Idiopathic/etiology , RNA, Messenger , SARS-CoV-2 , Vaccines, Synthetic , mRNA Vaccines
5.
Med Sci (Paris)
; 34(5): 406, 2018 May.
Article
in French
| MEDLINE
| ID: mdl-29900842